"Bromocriptine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion.
| Descriptor ID |
D001971
|
| MeSH Number(s) |
D03.132.327.412.100 D03.633.400.439.131 D03.633.400.562.100
|
| Concept/Terms |
Bromocriptine- Bromocriptine
- 2-Bromo-alpha-ergokryptine
- 2 Bromo alpha ergokryptine
- Bromocryptin
- 2-Bromoergokryptine
- 2 Bromoergokryptine
- Bromocriptin
- 2-Bromoergocryptine
- 2 Bromoergocryptine
- 2-Bromo-alpha-ergocryptine
- 2 Bromo alpha ergocryptine
2-Bromoergocryptine Mesylate- 2-Bromoergocryptine Mesylate
- 2 Bromoergocryptine Mesylate
- Mesylate, 2-Bromoergocryptine
- Bromocriptine Mesylate
- Mesylate, Bromocriptine
- 2-Bromoergocryptine Methanesulfonate
- 2 Bromoergocryptine Methanesulfonate
- Methanesulfonate, 2-Bromoergocryptine
|
Below are MeSH descriptors whose meaning is more general than "Bromocriptine".
Below are MeSH descriptors whose meaning is more specific than "Bromocriptine".
This graph shows the total number of publications written about "Bromocriptine" by people in this website by year, and whether "Bromocriptine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bromocriptine" by people in Profiles.
-
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012 May 09; 485(7398):333-8.
-
Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study. Cancer Causes Control. 2008 Dec; 19(10):1111-9.
-
Clinical presentation and response to therapy in patients with massive prolactin hypersecretion. Pituitary. 2007; 10(1):95-101.
-
Dopamine agonists reorient visual exploration away from the neglected hemispace. Neurology. 1998 Nov; 51(5):1395-8.
-
Galactorrhea. Curr Ther Endocrinol Metab. 1997; 6:393-6.
-
The neuroleptic malignant syndrome and acute renal failure. J Am Soc Nephrol. 1994 Jan; 4(7):1406-12.
-
Pergolide and bromocriptine for the treatment of patients with hyperprolactinemia. Am J Obstet Gynecol. 1986 Feb; 154(2):431-5.
-
Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists. Clin Neuropharmacol. 1986; 9(3):298-302.
-
Dopaminergic control of prolactin mRNA accumulation in the pituitary of the male rat. Mol Cell Endocrinol. 1981 Apr; 22(1):25-30.
-
Combined bromocryptine and hMG treatment in hyperprolactinemic infertility. Int J Fertil. 1981; 26(4):290-2.